Chief Executive Officer · AVADEL PHARMACEUTICALS PLC (AVDL)

Gregory Divis

A named executive officer of AVADEL PHARMACEUTICALS in every fiscal year CompBrief holds from FY2022 to FY2024. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2024

$7,399,605

Salary $651,600Stock awards $0

FY2023: $985,200

1st of 4 named executive officers at Avadel Pharmaceuticals by FY2024 total.

4 named officers on file for AVADEL PHARMACEUTICALS, FY2024

Gregory Divis’s pay file — $29

  • 3 fiscal years of pay, line by line
  • 1 equity grant, each cited to its filing
  • AVDL’s disclosed peer group of 16 companies

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how AVADEL PHARMACEUTICALS’s whole pay program stands against its peers

  • AVADEL PHARMACEUTICALS’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on AVDL→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed June 18, 2025 (DEF 14A). Insider transactions since that proxy, current to 2026-11-21.

Free

Get Gregory Divis’s pay history as a PDF, right here and by email

The PDF adds what this page leaves out: up to 10 years of pay, a peer comparison, and the board on one page. Two emails at most, nothing else.

Gregory Divis compensation by year

AVADEL PHARMACEUTICALS Summary Compensation Table · all 3 fiscal years held
In US dollars, as AVADEL PHARMACEUTICALS reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2022FY2023FY2024
Salary$561,144$600,000$651,600
Bonus$0$0$0
Stock awards$0$0$0
Option awards$0$0$6,722,205
Non-equity incentive$168,343$360,000$0
Pension and deferred compensation$0$0$0
All other$24,200$25,200$25,800
Total$753,687$985,200$7,399,605

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: AVADEL PHARMACEUTICALS PLC DEF 14A filed June 18, 2025, accession 0001104659-25-060465, and prior-year filings. Open the filing on EDGAR.

How this page was built: the AVADEL PHARMACEUTICALS PLC filed document, accession 0001104659-25-060465. Every figure is read from that document and cited to the page and table it appears in. Filed June 18, 2025.

$754K
$985K
$7.4M
FY22
FY23
FY24
SalaryNon-equity incentiveOption awardsAll other

Equity holdings

unvested awards at FY2024 year-end
TypeUnvested unitsValue at year-endExercise price
Option77,500—$8.20
Option600,000—$13.57

Per the Outstanding Equity Awards at Fiscal Year-End table in AVADEL PHARMACEUTICALS PLC's FY2024 proxy; value at the fiscal year-end close, as the company printed it.

Insider transactions since the last proxy

12 Form 4 lines since the FY2024 proxy (filed June 18, 2025)
current to 2026-11-21 · updated nightly
DateTransactionPlanSharesPriceHeld after
2026-02-12Disposition to the issuer—211,105$21.000
2026-02-12Disposition to the issuer—10,000$21.000
2026-02-12Disposition to the issuer derivative—150,000—0
2026-02-12Disposition to the issuer derivative—100,000—0
2026-02-12Disposition to the issuer derivative—50,000—0
2026-02-12Disposition to the issuer derivative—100,000—0
2026-02-12Disposition to the issuer derivative—400,000—0
2026-02-12Disposition to the issuer derivative—500,000—0

The 8 most recent of 12 lines, each as reported on the Form 4. "10b5-1" marks a trade the filing reports under a pre-arranged trading plan. View every Form 4 filing on EDGAR →

AVADEL PHARMACEUTICALS’s named executive officers, FY2024

as the company reported each
Named executive officerRoleFY2024 total
Gregory Divis · this pageChief Executive Officer$7,399,605
Richard KimFormer Chief Commercial Officer$2,754,301
Thomas McHughChief Financial Officer$2,294,698
Jerad SeurerGeneral Counsel & Corporate Secretary$2,035,159

The full AVADEL PHARMACEUTICALS compensation record

free company brief

This page is one person within AVADEL PHARMACEUTICALS's record. The company brief lists every named executive, each linking to their own page.

Peer companies

named in the AVADEL PHARMACEUTICALS proxy · each links to its own free brief

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are AVADEL PHARMACEUTICALS's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Gregory Divis's compensation dossier · One-time report. No refunds.